Skip to main content
Fig. 3 | Trials

Fig. 3

From: A multicentre, randomized, controlled open-label trial to compare an Accelerated Rule-Out protocol using combined prehospital copeptin and in-hospital high sensitive troponin with standard rule-out in patients suspected of acute Myocardial Infarction – the AROMI trial

Fig. 3

Study flowchart. Flowchart of patient courses in the two randomization groups. * Further diagnostic workup, including additional hs-ctn, is fully at the discretion of the attending physician. ** AMI is ruled out if both hs-ctn measurements are < 99th percentile URL or no significant rise or fall in hs-ctn is seen. *** AMI is ruled out if copeptin is < 95th percentile URL and hs-ctn < 99th percentile URL. AMI Acute myocardial infarction, hs-ctn High-sensitivity troponin, URL Upper reference limit

Back to article page

Trials

ISSN: 1745-6215